chromium picolinate vs zinc sulfate
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of chromium picolinate and zinc sulfate. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Chromium
Zinc, Orazinc
Chromium picolinate is a mineral supplement. It is used to support the pancreas.
Zinc sulfate is a mineral supplement. It can help with minor eye irritation.
This supplement is used to provide support to the pancreas. It is a homeo-nutritional product. This means the claims are based on traditional homeopathic practices.
This medicine can help with eye discomfort and redness. It is for minor eye irritations. It provides temporary relief.
This product is a mineral supplement. It is intended to provide nutritional support. It is not evaluated by the FDA.
Zinc sulfate works as a mild astringent. This means it can help to relieve minor eye irritation.
No common side effects listed.
No common side effects listed.
No adverse event reports.
- Diarrhoea 215
- Fatigue 172
- Nausea 166
- Death 153
- Pain 146
This product's claims have not been evaluated by the FDA.
No specific warnings noted.
No pregnancy information available.
It is not known if zinc sulfate can harm an unborn baby. Talk to your doctor if you are pregnant or breastfeeding.
Also Compare, Nearby Drugs
Compare chromium picolinate with
Compare zinc sulfate with
How to Read This chromium picolinate vs zinc sulfate Comparison
chromium picolinate is classified in the Mineral Supplement drug class, while zinc sulfate sits within the Mineral Supplement class. Because both drugs share the same classification, they are often considered interchangeable in theory, but clinical outcomes rarely track that cleanly. Both drugs are available over the counter.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, chromium picolinate has 0 submissions while zinc sulfate has 852. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for chromium picolinate or zinc sulfate.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.